Intelligence Platform
Patents
Browse 71 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted patentUS 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination wi
granted patentUS 12391734
PD-1 homing endonuclease variants, compositions, and methods of use
granted patentUS 12351633
PD-1 and PD-L1 binding agents
granted patentUS 12338269
IL-2 superagonists in combination with anti-PD-1 antibodies
granted patentUS 12325747
Human PD-L1 antibodies and methods of use therefor
granted patentUS 12286483
Method of treating cancer using CD137 antibodies and PD-1 antagonists
granted patentUS 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted patentUS 12187799
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor
granted patentUS 12168688
Antibodies and variants thereof against PD-L1
granted patentUS 12134648
Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
granted patentUS 12089575
Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
granted patentUS 12053534
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted patentUS 12054556
Anti-PD-L1 antibody and use thereof
granted patentUS 12054557
Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat
granted patentUS 12023355
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof
granted patentUS 12018015
Methods and compositions for targeting PD-L1
granted patentUS 11993655
Anti-PD-L1 antibody and use thereof
granted patentUS 11981736
Antibodies specific to glycosylated PD-1 and methods of use thereof
granted patentUS 11976128
Human PD-L2 antibodies and methods of use therefor
granted patentUS 11939581
Methods and compositions for targeting PD-L1
granted patentUS 11932692
Methods of treating cancer pain by administering a PD-1 inhibitor
granted patentUS 11926668
Anti-PD-1 antibodies for treatment of lung cancer
granted patentUS 11786553
Chimeric cytokine receptors bearing a PD-1 ectodomain
granted